NUVL
Price
$107.06
Change
+$2.82 (+2.71%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
7.58B
105 days until earnings call
Intraday BUY SELL Signals
VRDN
Price
$28.68
Change
+$0.09 (+0.31%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
2.73B
106 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NUVL vs VRDN

Header iconNUVL vs VRDN Comparison
Open Charts NUVL vs VRDNBanner chart's image
Nuvalent
Price$107.06
Change+$2.82 (+2.71%)
Volume$30.16K
Capitalization7.58B
Viridian Therapeutics
Price$28.68
Change+$0.09 (+0.31%)
Volume$8.33K
Capitalization2.73B
NUVL vs VRDN Comparison Chart in %
NUVL
Daily Signal:
Gain/Loss:
VRDN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NUVL vs. VRDN commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUVL is a Hold and VRDN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (NUVL: $104.24 vs. VRDN: $28.59)
Brand notoriety: NUVL and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NUVL: 224% vs. VRDN: 67%
Market capitalization -- NUVL: $7.58B vs. VRDN: $2.73B
NUVL [@Biotechnology] is valued at $7.58B. VRDN’s [@Biotechnology] market capitalization is $2.73B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NUVL’s FA Score shows that 0 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • NUVL’s FA Score: 0 green, 5 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVL is a better buy in the long-term than VRDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NUVL’s TA Score shows that 4 TA indicator(s) are bullish while VRDN’s TA Score has 4 bullish TA indicator(s).

  • NUVL’s TA Score: 4 bullish, 4 bearish.
  • VRDN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both NUVL and VRDN are a good buy in the short-term.

Price Growth

NUVL (@Biotechnology) experienced а +8.41% price change this week, while VRDN (@Biotechnology) price change was +0.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.28%. For the same industry, the average monthly price growth was -5.78%, and the average quarterly price growth was +64.80%.

Reported Earning Dates

NUVL is expected to report earnings on Mar 04, 2026.

VRDN is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (-2.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVL($7.58B) has a higher market cap than VRDN($2.73B). VRDN YTD gains are higher at: 49.139 vs. NUVL (33.163). VRDN has higher annual earnings (EBITDA): -340.62M vs. NUVL (-398.38M). NUVL has more cash in the bank: 943M vs. VRDN (563M). VRDN has higher revenues than NUVL: VRDN (305K) vs NUVL (0).
NUVLVRDNNUVL / VRDN
Capitalization7.58B2.73B278%
EBITDA-398.38M-340.62M117%
Gain YTD33.16349.13967%
P/E RatioN/AN/A-
Revenue0305K-
Total Cash943M563M167%
Total DebtN/A21.3M-
FUNDAMENTALS RATINGS
VRDN: Fundamental Ratings
VRDN
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
52
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NUVLVRDN
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
78%
Bearish Trend 16 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
NUVL
Daily Signal:
Gain/Loss:
VRDN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMQHX685.12N/A
N/A
Rydex Monthly Rbl NASDAQ-100® 2x Strt H
NSIDX14.79N/A
N/A
Northern Small Cap Index
FEIQX35.10N/A
N/A
Franklin Equity Income R6
CWMFX65.51-0.22
-0.33%
American Funds Washington Mutual 529F1
TIVFX20.35-0.44
-2.12%
American Beacon IMC Int Small Cap Inv

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with RVMD. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
-3.48%
RVMD - NUVL
61%
Loosely correlated
+2.07%
XNCR - NUVL
60%
Loosely correlated
+2.62%
IDYA - NUVL
59%
Loosely correlated
+1.08%
XENE - NUVL
59%
Loosely correlated
N/A
CGON - NUVL
58%
Loosely correlated
+3.15%
More

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with NUVL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
-1.41%
NUVL - VRDN
56%
Loosely correlated
-3.48%
SYRE - VRDN
53%
Loosely correlated
-1.07%
AGIO - VRDN
51%
Loosely correlated
+0.80%
OCUL - VRDN
51%
Loosely correlated
-1.09%
XNCR - VRDN
50%
Loosely correlated
+2.62%
More